John Morris on Aducanumab Still Needs to Prove Itself, Researchers Say
COMMENT In 37 years of caring for persons with Alzheimer’s disease dementia, and in conducting clinical and translational research to advance the development of truly effective therapies for the disorder, I am very excited that a candidate mechanism-based drug, ...